Medtronic advances its innovation strategy with intent to acquire CathWorks
Deal demonstrates Medtronic’s commitment to expanding pipeline through strategic investments and targeted acquisitions Exercising option to acquire will bolster Medtronic’s interventional cardiology portfolio, expanding its leadership in transforming how cardiovascular disease is diagnosed and treated Medtronic’s intent to acquire follows a 2022 strategic partnership agreement with CathWorks Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it…
